**Core Concept**
The management of asthma requires a stepwise approach to optimize treatment and control symptoms. This involves assessing the severity of asthma, monitoring symptoms, and adjusting treatment accordingly. In patients with intermittent asthma, the goal is to prevent symptoms and maintain optimal lung function.

**Why the Correct Answer is Right**
The patient's frequent nocturnal coughing despite good inhaler technique and compliance suggests that her current treatment regimen may not be sufficient to control her asthma. Stepwise management of asthma involves increasing treatment intensity if symptoms persist or worsen. In this case, adding a low-dose inhaled corticosteroid (ICS) is a logical next step to control inflammation and prevent nocturnal symptoms. ICS can be added to the existing salbutamol inhaler to enhance asthma control and prevent exacerbations.

**Why Each Wrong Option is Incorrect**
**Option A:** Increasing the frequency of salbutamol inhaler use may not address the underlying inflammation driving nocturnal symptoms. This approach may lead to tolerance and dependence on rescue medication.

**Option B:** Switching to a different inhaler device or technique may not address the underlying issue of inadequate asthma control. Good inhaler technique is crucial, but it may not be sufficient to control symptoms in this patient.

**Option C:** Adding a long-acting beta-agonist (LABA) without an ICS would be inappropriate in this scenario. LABAs are not recommended as monotherapy in patients with asthma due to the risk of exacerbating symptoms and increasing the risk of asthma-related death.

**Clinical Pearl / High-Yield Fact**
Remember the " Asthma Control Test" (ACT) to assess asthma control: symptoms, rescue medication use, lung function, and exacerbations. The ACT can help guide treatment decisions and ensure that patients receive the most appropriate therapy for their level of asthma control.

**Correct Answer:** C. Adding a low-dose inhaled corticosteroid (ICS) to the existing salbutamol inhaler is the most appropriate next step in managing this patient's asthma.